ecrin-mdr-crcClinical2009Metastatic Colorectal CancerCáncer colorrectal metastásico no pretratadoColorectal NeoplasmsColorectal cancer NOSMetastatic Colorectal CancerCáncer Colorrectal Metastásico No PretratadoColorectal NeoplasmsColorectal Cancer NosInterventionalhttps://newmdr.ecrin.org/Study/2070371Spain4IrinotecanXeloda 150mg.Avastin 400mg.CapecitabineXeloda 500mg.Avastin 100mg.BevacizumabECRIN MDRCompletedfalseIrinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer PatientsThe purpose of this study is to determine efficacy and safety of the biweekly scheme with Capecitabine and Irinotecan, plus bevacizumab in patients with metastatic colorectal cancer.2009-04-152070371NCT008757712008-004688-20